Observe Medical ASA (OSL:OBSRV)
Norway · Delayed Price · Currency is NOK 1.180
-0.020 (-1.67%)
At close: Jul 22, 2025
Observe Medical ASA Revenue
In the year 2024, Observe Medical ASA had annual revenue of 18.48M NOK, down -33.85%. Observe Medical ASA had revenue of 5.43M in the half year ending December 31, 2024, a decrease of -27.76%.
Revenue
18.48M
Revenue Growth
-33.85%
P/S Ratio
5.88
Revenue / Employee
3.70M
Employees
5
Market Cap
108.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.48M | -9.46M | -33.85% |
| Dec 31, 2023 | 27.94M | 8.42M | 43.14% |
| Dec 31, 2022 | 19.52M | -4.52M | -18.80% |
| Dec 31, 2021 | 24.04M | 21.08M | 711.96% |
| Dec 31, 2020 | 2.96M | 2.78M | 1,572.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 442.14M |
| ArcticZymes Technologies ASA | 102.97M |
| Gentian Diagnostics ASA | 163.38M |
| Lytix Biopharma AS | 608.00K |